Home › Companies › EDITAS MEDICINE INC. › 2024-2025
Compiled from SEC Form N-PX filings and EDITAS MEDICINE INC.’s Form 8-K, filed June 2, 2025 (Item 5.07 on EDGAR). Page generated October 18, 2026.
Meeting of May 29, 2025: 7 items on EDITAS MEDICINE INC.’s Form 8-K, filed June 2, 2025: 4 approved · 3 without a stated outcome.
Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided
Explore EDITAS MEDICINE INC. in the interactive database Compare manager voting policies
These tallies are EDITAS MEDICINE INC.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 2, 2025 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jessica Hopfield, Ph.D. | 21,212,129 | -- | -- | 5,317,351 | 26,052,859 | 80% | Not verified | — |
| Elect Director: David Scadden, M.D. | 24,052,406 | -- | -- | 2,477,074 | 26,052,859 | 91% | Not verified | — |
| 2. The compensation paid to its named executive officers | 16,066,738 | 10,241,052 | 221,690 | -- | 26,052,859 | 61% | Approved | — |
| 3. A frequency of one year for future advisory votes on the compensation paid to its named executive officers | 25,160,123 | -- | 316,138 | -- | 26,052,859 | — | Not verified | — |
| 4. An amendment and restatement of the Company's 2015 Stock Incentive Plan | 20,101,589 | 6,265,763 | 162,128 | -- | 26,052,859 | 76% | Approved | — |
| 5. And approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Company's common stock fro | 38,719,409 | 13,205,693 | 657,237 | -- | 0 | 75% | Approved | — |
| 6. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year | 51,108,970 | 1,162,233 | 311,136 | -- | 0 | 98% | Approved | — |
Source: EDITAS MEDICINE INC., Form 8-K, filed with the SEC on June 2, 2025 — read the filing on EDGAR.
Each item below shows how the 232 asset managers that disclosed a EDITAS MEDICINE INC. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report. These are reported items, not a count of the ballot: fund filings describe one ballot item in different words. Two descriptions are shown as one item only on evidence — the same text (or one cut short of the other), the same director nominee, or a match to the same row of EDITAS MEDICINE INC.’s own Form 8-K tally — never because they merely read alike. A description that could not be joined that way is listed on its own, so one ballot item can appear more than once.
Combines 4 wordings of this item as funds reported it.
91% Majority: yes · of votes cast
Description as filed by funds: Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: David T. Scadden, M.D.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: David Scadden, M.D.”): 24,052,406 for, 2,477,074 withheld, per its Form 8-K filed June 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 91% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 12,579,309 for, 423,528 withheld, 91,911 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,723,470 | 0 | 0 | 0 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 245,741 | Withhold |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 14,369 | 0 | 0 | 133,630 | Mixed |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 0 | 75,674 | 0 | Abstain |
| Lincoln Financial | 61,938 | 0 | 0 | 3,993 | Mixed |
| Thrivent | 59,541 | 0 | 0 | 0 | For |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 0 | 0 | 39,798 | Withhold |
| Invesco | 36,296 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
| Voya | 24,546 | 0 | 0 | 0 | For |
| ProShares | 22,932 | 0 | 0 | 0 | For |
| John Hancock | 15,423 | 0 | 4,847 | 0 | Mixed |
| BRIDGEWAY FUNDS INC | 20,000 | 0 | 0 | 0 | For |
| Allspring | 18,979 | 0 | 0 | 0 | For |
| Blackstone Alternative Investment Funds | 18,600 | 0 | 0 | 0 | For |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 4 wordings of this item as funds reported it.
80% Majority: yes · of votes cast
Description as filed by funds: Election of two Class III Directors, each to serve until the 2028 annual meeting of stockholders: Jessica Hopfield, Ph.D.
EDITAS MEDICINE INC.’s own tally for this item (“Elect Director: Jessica Hopfield, Ph.D.”): 21,212,129 for, 5,317,351 withheld, per its Form 8-K filed June 2, 2025 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: not verified — the filing’s own statement of the outcome could not be identified for this item.
Support: 80% of votes cast — FOR ÷ (FOR + WITHHELD); abstentions and broker non-votes are excluded.
The 45 asset managers below reported 12,124,544 for, 862,870 withheld, 107,334 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,705,970 | 0 | 0 | 17,500 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 0 | 0 | 245,741 | Withhold |
| Goldman Sachs | 0 | 0 | 0 | 191,451 | Withhold |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 14,369 | 0 | 0 | 133,630 | Mixed |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 0 | 75,674 | 0 | Abstain |
| Lincoln Financial | 61,938 | 0 | 0 | 3,993 | Mixed |
| Thrivent | 0 | 0 | 0 | 59,541 | Withhold |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 0 | 0 | 0 | 36,296 | Withhold |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 0 | 0 | 31,670 | Withhold |
| Voya | 0 | 0 | 0 | 24,546 | Withhold |
| ProShares | 0 | 0 | 0 | 22,932 | Withhold |
| John Hancock | 0 | 0 | 20,270 | 0 | Abstain |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 20,000 | Withhold |
| Allspring | 0 | 0 | 0 | 18,979 | Withhold |
| Blackstone Alternative Investment Funds | 0 | 0 | 0 | 18,600 | Withhold |
Showing the 25 largest of 45 asset managers. See all 45 in the interactive database.
Combines 3 wordings of this item as funds reported it.
75% Approved · of votes cast
Description as filed by funds: TO ADOPT AND APPROVE AN AMENDMENT TO THE COMPANY'S RESTATED CERTIFICATE OF INCORPORATION TO INCREASE THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY'S CAPITAL STOCK FROM 200,000,000 TO 395,000,000 AND THE NUMBER OF AUTHORIZED SHARES OF THE COMPANY'S COMMON STOCK FROM 195,000,000 TO 390,000,000.
EDITAS MEDICINE INC.’s own tally for this item (“5. And approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized ”): 38,719,409 for, 13,205,693 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders adopted and approved an amendment to the Company's Restated Certificate of Incorporation to increase the number of authorized shares of the Company's capital stock from 200,000,000 to 395,000,000 and the number of authorized shares of the Company's common stock from 195,0…”
Support: 75% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 48 asset managers below reported 10,369,088 for, 2,798,286 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 17,500 | 1,705,970 | 0 | 0 | Against |
| Charles Schwab | 0 | 684,883 | 0 | 0 | Against |
| Dimensional | 245,741 | 0 | 0 | 0 | For |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 0 | 175,038 | 0 | 0 | Against |
| Equitable | 147,999 | 0 | 0 | 0 | For |
| Global X | 0 | 147,410 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 65,931 | 0 | 0 | 0 | For |
| Thrivent | 59,541 | 0 | 0 | 0 | For |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 36,296 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
| Voya | 24,546 | 0 | 0 | 0 | For |
| ProShares | 22,932 | 0 | 0 | 0 | For |
| John Hancock | 20,270 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 20,000 | 0 | 0 | 0 | For |
| Allspring | 18,979 | 0 | 0 | 0 | For |
Showing the 25 largest of 48 asset managers. See all 48 in the interactive database.
Combines 4 wordings of this item as funds reported it.
76% Approved · of votes cast
Description as filed by funds: TO APPROVE AN AMENDMENT AND RESTATEMENT OF THE COMPANY'S 2015 STOCK INCENTIVE PLAN.
EDITAS MEDICINE INC.’s own tally for this item (“4. An amendment and restatement of the Company's 2015 Stock Incentive Plan”): 20,101,589 for, 6,265,763 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders approved an amendment and restatement of the Company's 2015 Stock Incentive Plan.”
Support: 76% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 51 asset managers below reported 12,384,571 for, 782,945 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,705,970 | 17,500 | 0 | 0 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 0 | 245,741 | 0 | 0 | Against |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 14,369 | 133,630 | 0 | 0 | Mixed |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 61,938 | 3,993 | 0 | 0 | Mixed |
| Thrivent | 0 | 59,541 | 0 | 0 | Against |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 0 | 36,296 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 31,670 | 0 | 0 | Against |
| Voya | 0 | 24,546 | 0 | 0 | Against |
| ProShares | 0 | 22,932 | 0 | 0 | Against |
| John Hancock | 0 | 20,270 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 20,000 | 0 | 0 | Against |
| Allspring | 0 | 18,979 | 0 | 0 | Against |
Showing the 25 largest of 51 asset managers. See all 51 in the interactive database.
Combines 8 wordings of this item as funds reported it.
90% Fund and manager reports combined; may count the same shares twice · no official result
Description as filed by funds: To approve, on an advisory basis, the frequency of future advisory votes on the compensation paid to the Company's named executive officers.
Also reported under other wordings, matched to the same row of EDITAS MEDICINE INC.’s official tally and shown with their own fund figures; their managers are not in the figures or the table on this card: “Advisory Vote on Say on Pay Frequency” (2 managers, 735,020 1 year).
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 0 | 0 | 0 | 0 | -- |
| BlackRock | 0 | 0 | 0 | 0 | -- |
| Fidelity | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| Goldman Sachs | 0 | 0 | 0 | 0 | -- |
| SEI | 0 | 0 | 0 | 0 | -- |
| Equitable | 0 | 0 | 0 | 0 | -- |
| Global X | 0 | 0 | 0 | 0 | -- |
| QUANTITATIVE MASTER SERIES LLC | 0 | 0 | 0 | 0 | -- |
| Amplify ETF Trust | 0 | 0 | 0 | 0 | -- |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 0 | 0 | 0 | 0 | -- |
| Thrivent | 0 | 0 | 0 | 0 | -- |
| Pacific Life | 0 | 0 | 0 | 0 | -- |
| Bridge Builder Trust | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| MASTER INVESTMENT PORTFOLIO | 0 | 0 | 0 | 0 | -- |
| Listed Funds Trust | 0 | 0 | 0 | 0 | -- |
| Voya | 0 | 0 | 0 | 0 | -- |
| ProShares | 0 | 0 | 0 | 0 | -- |
| John Hancock | 0 | 0 | 0 | 0 | -- |
| BRIDGEWAY FUNDS INC | 0 | 0 | 0 | 0 | -- |
| Allspring | 0 | 0 | 0 | 0 | -- |
Fund voting reports, all 45 managers: 71,526 for, 12,829,237 1 year, 265,491 3 year. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 0 | 0 | 0 | 0 | -- |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 0 | 0 | 0 | -- |
| State Street | 0 | 0 | 0 | 0 | -- |
| Charles Schwab | 0 | 0 | 0 | 0 | Not Voted |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 0 | 0 | 0 | -- |
| UBS | 0 | 0 | 0 | 0 | -- |
| Northern Trust | 0 | 0 | 0 | 0 | -- |
| KENNEDY CAPITAL MANAGEMENT LLC | 0 | 0 | 0 | 0 | -- |
| DE Shaw | 0 | 0 | 0 | 0 | -- |
| Renaissance | 0 | 0 | 0 | 0 | -- |
| Vanguard | 0 | 0 | 0 | 0 | -- |
| Green Alpha Advisors, LLC | 203,658 | 0 | 0 | 0 | For |
| SEI | 0 | 0 | 0 | 0 | -- |
| Dimensional | 0 | 0 | 0 | 0 | -- |
| MARSHALL WACE, LLP | 0 | 0 | 0 | 0 | -- |
| MELLON INVESTMENTS Corp | 0 | 0 | 0 | 0 | -- |
| AQR | 0 | 0 | 0 | 0 | -- |
| AllianceBernstein | 0 | 0 | 0 | 0 | -- |
| Nuveen | 0 | 0 | 0 | 0 | -- |
| Invesco | 0 | 0 | 0 | 0 | -- |
| Prudential/PGIM | 0 | 0 | 0 | 0 | -- |
| Texas Yale Capital Corp. | 0 | 0 | 0 | 0 | -- |
| Thrivent | 0 | 0 | 0 | 0 | -- |
| Two Sigma | 0 | 0 | 0 | 0 | -- |
| Rhumbline | 0 | 27,416 | 0 | 0 | Against |
Institutional-manager reports, all 197 managers: 208,617 for, 29,593 against, 770 abstained, 13,731 not voted, 9,199,974 1 year, 172,619 3 year, 80 2 year, 50 unknown. Showing the 25 largest; see all in the interactive database.
Combines 4 wordings of this item as funds reported it.
59% Fund and manager reports combined; may count the same shares twice · no official result
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice). The figure above is FOR ÷ (FOR + AGAINST + WITHHELD) of the shares these managers voted; abstained and unvoted shares are in neither half, and these managers are a subset of all shareholders, not the meeting result.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 0 | 2,107,181 | 0 | 0 | Against |
| Fidelity | 1,705,970 | 17,500 | 0 | 0 | For |
| Charles Schwab | 0 | 684,883 | 0 | 0 | Against |
| Dimensional | 0 | 245,741 | 0 | 0 | Against |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 0 | 147,999 | 0 | 0 | Against |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 114,842 | 0 | 0 | Against |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 0 | 71,526 | 0 | 0 | Against |
| Lincoln Financial | 61,938 | 3,993 | 0 | 0 | Mixed |
| Thrivent | 0 | 59,541 | 0 | 0 | Against |
| Pacific Life | 0 | 48,074 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 39,850 | 0 | 0 | Against |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 0 | 36,296 | 0 | 0 | Against |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 0 | 31,670 | 0 | 0 | Against |
| Voya | 0 | 24,546 | 0 | 0 | Against |
| ProShares | 0 | 22,932 | 0 | 0 | Against |
| John Hancock | 0 | 20,270 | 0 | 0 | Against |
| BRIDGEWAY FUNDS INC | 0 | 20,000 | 0 | 0 | Against |
| Allspring | 0 | 18,979 | 0 | 0 | Against |
Fund voting reports, all 45 managers: 9,308,593 for, 3,857,661 against. Showing the 25 largest; see all in the interactive database.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| BlackRock | 48,577 | 1,891,045 | 0 | 0 | Against |
| GEODE CAPITAL MANAGEMENT, LLC | 1,856,777 | 0 | 0 | 0 | For |
| State Street | 896,309 | 5,261 | 0 | 0 | For |
| Charles Schwab | 0 | 684,896 | 0 | 0 | Against |
| STIFEL NICOLAUS & CO INC \MO\ | 0 | 364,720 | 0 | 0 | Against |
| UBS | 0 | 360,502 | 0 | 0 | Against |
| Northern Trust | 324,769 | 0 | 0 | 0 | For |
| KENNEDY CAPITAL MANAGEMENT LLC | 0 | 307,144 | 0 | 0 | Against |
| DE Shaw | 0 | 227,317 | 0 | 0 | Against |
| Renaissance | 0 | 205,937 | 0 | 0 | Against |
| Vanguard | 182,062 | 23,492 | 0 | 0 | Mixed |
| SEI | 175,508 | 0 | 0 | 0 | For |
| Dimensional | 0 | 172,529 | 0 | 0 | Against |
| MARSHALL WACE, LLP | 144,306 | 0 | 0 | 0 | For |
| MELLON INVESTMENTS Corp | 143,342 | 0 | 0 | 0 | For |
| AQR | 0 | 137,119 | 0 | 0 | Against |
| AllianceBernstein | 0 | 133,630 | 0 | 0 | Against |
| Nuveen | 0 | 85,595 | 0 | 0 | Against |
| Invesco | 0 | 81,608 | 0 | 0 | Against |
| Prudential/PGIM | 0 | 70,507 | 0 | 0 | Against |
| Texas Yale Capital Corp. | 70,000 | 0 | 0 | 0 | For |
| Thrivent | 0 | 61,111 | 0 | 0 | Against |
| Two Sigma | 0 | 56,011 | 0 | 0 | Against |
| Rhumbline | 0 | 27,416 | 0 | 0 | Against |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 0 | 43,375 | 0 | 0 | Against |
Institutional-manager reports, all 197 managers: 4,059,650 for, 5,321,366 against, 770 abstained, 13,731 not voted, 27,416 1 year. Showing the 25 largest; see all in the interactive database.
Combines 2 wordings of this item as funds reported it.
98% Approved · of votes cast
Description as filed by funds: TO RATIFY THE APPOINTMENT OF ERNST & YOUNG LLP AS THE COMPANY'S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2025.
EDITAS MEDICINE INC.’s own tally for this item (“6. The selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year”): 51,108,970 for, 1,162,233 against — passed, per its Form 8-K filed June 2, 2025 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “The Company's stockholders ratified the selection of Ernst & Young LLP as the Company's independent registered public accounting firm for the current fiscal year.”
Support: 98% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 47 asset managers below reported 13,090,754 for, 76,520 against.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 6,934,797 | 0 | 0 | 0 | For |
| BlackRock | 2,107,181 | 0 | 0 | 0 | For |
| Fidelity | 1,723,470 | 0 | 0 | 0 | For |
| Charles Schwab | 684,883 | 0 | 0 | 0 | For |
| Dimensional | 245,741 | 0 | 0 | 0 | For |
| Goldman Sachs | 191,451 | 0 | 0 | 0 | For |
| SEI | 175,038 | 0 | 0 | 0 | For |
| Equitable | 147,999 | 0 | 0 | 0 | For |
| Global X | 147,410 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 114,842 | 0 | 0 | 0 | For |
| Amplify ETF Trust | 0 | 75,674 | 0 | 0 | Against |
| Investment Managers Series Trust II | 71,526 | 0 | 0 | 0 | For |
| Lincoln Financial | 65,931 | 0 | 0 | 0 | For |
| Thrivent | 59,541 | 0 | 0 | 0 | For |
| Pacific Life | 48,074 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 39,850 | 0 | 0 | 0 | For |
| Northern Trust | 39,798 | 0 | 0 | 0 | For |
| Invesco | 36,296 | 0 | 0 | 0 | For |
| MASTER INVESTMENT PORTFOLIO | 34,530 | 0 | 0 | 0 | For |
| Listed Funds Trust | 31,670 | 0 | 0 | 0 | For |
| Voya | 24,546 | 0 | 0 | 0 | For |
| ProShares | 22,932 | 0 | 0 | 0 | For |
| John Hancock | 20,270 | 0 | 0 | 0 | For |
| BRIDGEWAY FUNDS INC | 20,000 | 0 | 0 | 0 | For |
| Allspring | 18,979 | 0 | 0 | 0 | For |
Showing the 25 largest of 47 asset managers. See all 47 in the interactive database.
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 83,709,536 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 8.28% |
| 2 | BlackRock | 2.52% |
| 3 | Fidelity | 2.06% |
| 4 | Charles Schwab | 0.82% |
| 5 | Dimensional | 0.29% |
| 6 | Goldman Sachs | 0.23% |
| 7 | SEI | 0.21% |
| 8 | Equitable | 0.18% |
| 9 | Global X | 0.18% |
| 10 | QUANTITATIVE MASTER SERIES LLC | 0.14% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | BlackRock | 2.32% |
| 2 | GEODE CAPITAL MANAGEMENT, LLC | 2.22% |
| 3 | State Street | 1.08% |
| 4 | Charles Schwab | 0.83% |
| 5 | STIFEL NICOLAUS & CO INC \MO\ | 0.44% |
| 6 | UBS | 0.43% |
| 7 | Northern Trust | 0.39% |
| 8 | KENNEDY CAPITAL MANAGEMENT LLC | 0.37% |
| 9 | DE Shaw | 0.27% |
| 10 | Renaissance | 0.25% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.
| Holder | % outstanding | Disclosure |
|---|---|---|
| Commodore Capital LP | 19.17% | 13G |
| TCG Crossover GP III, LLC | 18.87% | 13G |
| Vanguard Group | 8.92% | 13F |
| BlackRock | 7.99% | 13F |
| Morgan Stanley | 3.18% | 13F |
| Geode Capital | 2.32% | 13F |
| State Street | 2.21% | 13F |
| Dimensional Fund Advisors | 1.92% | 13F |
| Two Sigma | 1.49% | 13F |
| Renaissance Technologies | 1.23% | 13F |
Percentages above are of 83,709,536 shares outstanding, as reported by EDITAS MEDICINE INC. on its Form 10-Q dated March 31, 2025 (see the filing on EDGAR). This is the count contemporaneous with the 2024-2025 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from EDITAS MEDICINE INC.’s 10-Q dated March 31, 2025. This page is a static snapshot rebuilt weekly on October 18, 2026; a live search always shows the current data.
At EDITAS MEDICINE INC.'s shareholder meeting held May 29, 2025, in the 2024-2025 proxy season, 232 asset managers reported how they voted in their SEC Form N-PX filings, covering 1,417 separate fund positions. Their filings are grouped here into 7 reported items; because filers word the same ballot item differently, that can be more than the number of items on the ballot. EDITAS MEDICINE INC.'s own Form 8-K tally for this meeting is published below, but no row in it could be matched to the most widely held item, so this page states no certified outcome for that item. On that item — To approve, on an advisory basis, the frequency of future advisory votes on the compensation… — the reporting funds and managers cast 90% of the shares they voted in favour (FOR divided by FOR plus AGAINST plus WITHHELD; abstained and unvoted shares are excluded because neither took a side). Fund and manager reports are combined in it and may count the same shares twice: it adds fund reports to institutional-manager reports, which can cover the same shares. It is not the company's certified result.
EDITAS MEDICINE INC. proxy season coverage: 2023-2024 · 2024-2025 (this page) · 2025-2026.
Download data (CSV): ballot items · votes by manager · column guide.